Search Results

AEE788 2 mg  | Purity Not Available

TargetMol

AEE788 has been used in trials studying the treatment of Cancer, Glioblastoma Multiforme, and Brain and Central Nervous System Tumors.

More Information Supplier Page

FH1 200 mg  | 99.95%

TargetMol

FH1 (BRD-K4477), a small molecule, enhances the functions of hepatocytes and promotes differentiation hepatocytes derived by iPS.

More Information Supplier Page

FH1 100 mg  | 99.95%

TargetMol

FH1 (BRD-K4477), a small molecule, enhances the functions of hepatocytes and promotes differentiation hepatocytes derived by iPS.

More Information Supplier Page

Navitoclax 200 mg  | 98.88%

TargetMol

Navitoclax (ABT-263) is a potent, orally bioavailable Bcl-2 family protein inhibitor that avidly binds Bcl-2, Bcl-xL, and Bcl-W (Ki < 1 nM for all three proteins).

More Information Supplier Page

Yohimbine hydrochloride 200 mg  | 99.98%

TargetMol

Yohimbine hydrochloride (Antagonil) is a plant alkaloid with alpha-2-adrenergic blocking activity. Yohimbine has been used as a mydriatic and in the treatment of ERECTILE DYSFUNCTION.

More Information Supplier Page